Skip to main content

AML with t(8;16) mimicking acute promyelocytic leukaemia

Meer van International Journal of Laboratory Hematology
Home

Oncologieportal

Gerelateerd

  • FDA Updates Reports of Breast Implant-Related Cancer, Illness
  • Hydrochlorothiazide Label Warns of Risk for Non-Melanoma Skin Cancers
  • Is ovarian cancer surgery stuck in the dark ages?: a commentary piece reviewing surgical technologies

Tags

Trending

  • Targeting EGFR in melanoma – The sea of possibilities to overcome drug resistance
  • Long-Term Survival in a Significant Proportion of Patients with a 1p/19q Codeleted Anaplastic Oligodendroglioma
  • [Corrections] Correction to Lancet Oncol 2022; 23: 888–98
  • [Corrections] Correction to Lancet Oncol 2022; 23: 304–16
  • [Correspondence] How molecularly similar are primary and metastatic tissues in renal cell carcinoma?
  • [Correspondence] Optimal molecular selection to benefit from nivolumab–ipilimumab in clear-cell renal cell carcinoma

Log in met Medi-Access

Wilt u het gehele artikel lezen?
Log in met Medi-Access om verder te lezen

Login Registreren

AML with t(8;16) mimicking acute promyelocytic leukaemia

International Journal of Laboratory Hematology | Geplaatst op 26.05.2022 13:32